메뉴 건너뛰기




Volumn 1, Issue 3, 2016, Pages 341-349

Drugs for primary prevention of atherosclerotic cardiovascular disease: An overview of systematic reviews

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 85016572589     PISSN: 23806583     EISSN: 23806591     Source Type: Journal    
DOI: 10.1001/jamacardio.2016.0218     Document Type: Review
Times cited : (72)

References (54)
  • 1
    • 80053344963 scopus 로고    scopus 로고
    • The "Million hearts" initiative: Preventing heart attacks and strokes
    • Frieden TR, Berwick DM. The "Million Hearts" initiative: preventing heart attacks and strokes. N Engl J Med. 2011; 365(13):e27.
    • (2011) N Engl J Med. , vol.365 , Issue.13 , pp. e27
    • Frieden, T.R.1    Berwick, D.M.2
  • 2
    • 77952326558 scopus 로고    scopus 로고
    • Deaths preventable in the U.S. by improvements in use of clinical preventive services
    • Farley TA, Dalal MA, Mostashari F, Frieden TR. Deaths preventable in the U.S. by improvements in use of clinical preventive services. Am J Prev Med. 2010; 38(6):600-609.
    • (2010) Am J Prev Med. , vol.38 , Issue.6 , pp. 600-609
    • Farley, T.A.1    Dalal, M.A.2    Mostashari, F.3    Frieden, T.R.4
  • 3
    • 84937469509 scopus 로고    scopus 로고
    • Paying for prevention: A novel test of medicare value-based payment for cardiovascular risk reduction
    • Sanghavi DM, Conway PH. Paying for prevention: a novel test of Medicare value-based payment for cardiovascular risk reduction. JAMA. 2015; 314(2):123-124.
    • (2015) JAMA , vol.314 , Issue.2 , pp. 123-124
    • Sanghavi, D.M.1    Conway, P.H.2
  • 5
    • 72949097216 scopus 로고    scopus 로고
    • How canwe support the use of systematic reviews in policymaking?
    • Lavis JN. How canwe support the use of systematic reviews in policymaking? PLoS Med. 2009; 6(11):e1000141.
    • (2009) PLoS Med. , vol.6 , Issue.11 , pp. e1000141
    • Lavis, J.N.1
  • 6
    • 84866945196 scopus 로고    scopus 로고
    • The evolution of a new publication type: Steps and challenges of producing overviews of reviews
    • Thomson D, Russell K, Becker L, Klassen T, Hartling L. The evolution of a new publication type: steps and challenges of producing overviews of reviews. Res Synth Methods. 2010; 1(3-4):198-211.
    • (2010) Res Synth Methods , vol.1 , Issue.3-4 , pp. 198-211
    • Thomson, D.1    Russell, K.2    Becker, L.3    Klassen, T.4    Hartling, L.5
  • 7
    • 84919364147 scopus 로고    scopus 로고
    • The benefits and challenges of conducting an overview of systematic reviews in public health: A focus on physical activity
    • Baker PR, Costello JT, Dobbins M, Waters EB. The benefits and challenges of conducting an overview of systematic reviews in public health: a focus on physical activity. J Public Health (Oxf). 2014; 36(3):517-521.
    • (2014) J Public Health (Oxf) , vol.36 , Issue.3 , pp. 517-521
    • Baker, P.R.1    Costello, J.T.2    Dobbins, M.3    Waters, E.B.4
  • 10
    • 33847606952 scopus 로고    scopus 로고
    • Development of AMSTAR: A measurement tool to assess the methodological quality of systematic reviews
    • Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; 7:10.
    • (2007) BMC Med Res Methodol. , vol.7 , pp. 10
    • Shea, B.J.1    Grimshaw, J.M.2    Wells, G.A.3
  • 11
    • 84876197996 scopus 로고    scopus 로고
    • Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior
    • Cheung A, Weir M, Mayhew A, Kozloff N, Brown K, Grimshaw J. Overview of systematic reviews of the effectiveness of reminders in improving healthcare professional behavior. Syst Rev. 2012; 1: 36.
    • (2012) Syst Rev. , vol.1 , pp. 36
    • Cheung, A.1    Weir, M.2    Mayhew, A.3    Kozloff, N.4    Brown, K.5    Grimshaw, J.6
  • 12
    • 79551512111 scopus 로고    scopus 로고
    • Methodology inconductinga systematic review of systematic reviews of healthcare interventions
    • Smith V, Devane D, Begley CM, Clarke M. Methodology inconductinga systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011; 11(1):15.
    • (2011) BMC Med Res Methodol. , vol.11 , Issue.1 , pp. 15
    • Smith, V.1    Devane, D.2    Begley, C.M.3    Clarke, M.4
  • 13
    • 43049113533 scopus 로고    scopus 로고
    • GRADE: An emerging consensus on rating quality of evidence and strength of recommendations
    • Guyatt GH, Oxman AD, Vist GE, et al.; GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-926.
    • (2008) BMJ , vol.336 , Issue.7650 , pp. 924-926
    • Guyatt, G.H.1    Oxman, A.D.2    Vist, G.E.3
  • 14
    • 65849268320 scopus 로고    scopus 로고
    • Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
    • Baigent C, Blackwell L, Collins R, et al.; Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009; 373(9678):1849-1860.
    • (2009) Lancet. , vol.373 , Issue.9678 , pp. 1849-1860
    • Baigent, C.1    Blackwell, L.2    Collins, R.3
  • 15
    • 79960200973 scopus 로고    scopus 로고
    • Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: A meta-analysis of randomized trials
    • Berger JS, Lala A, Krantz MJ, Baker GS, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials. Am Heart J. 2011; 162(1):115-24.e2.
    • (2011) Am Heart J. , vol.162 , Issue.1 , pp. 115-242
    • Berger, J.S.1    Lala, A.2    Krantz, M.J.3    Baker, G.S.4    Hiatt, W.R.5
  • 16
    • 30944467297 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials
    • Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA. 2006; 295(3): 306-313.
    • (2006) JAMA , vol.295 , Issue.3 , pp. 306-313
    • Berger, J.S.1    Roncaglioni, M.C.2    Avanzini, F.3    Pangrazzi, I.4    Tognoni, G.5    Brown, D.L.6
  • 17
    • 84939995659 scopus 로고    scopus 로고
    • A systematic review of aspirin in primary prevention: Is it time for a new approach?
    • Brotons C, Benamouzig R, Filipiak KJ, Limmroth V, Borghi C. A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs. 2015; 15(2):113-133.
    • (2015) Am J Cardiovasc Drugs , vol.15 , Issue.2 , pp. 113-133
    • Brotons, C.1    Benamouzig, R.2    Filipiak, K.J.3    Limmroth, V.4    Borghi, C.5
  • 18
    • 79953246984 scopus 로고    scopus 로고
    • Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: A systematic review and meta-analysis
    • Butalia S, Leung AA, Ghali WA, Rabi DM. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc Diabetol. 2011; 10:25.
    • (2011) Cardiovasc Diabetol. , vol.10 , pp. 25
    • Butalia, S.1    Leung, A.A.2    Ghali, W.A.3    Rabi, D.M.4
  • 19
    • 72249095825 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events: A systematic review and meta-analysis comparing patients with and without diabetes
    • Calvin AD, Aggarwal NR, Murad MH, et al. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care. 2009; 32(12):2300-2306.
    • (2009) Diabetes Care , vol.32 , Issue.12 , pp. 2300-2306
    • Calvin, A.D.1    Aggarwal, N.R.2    Murad, M.H.3
  • 20
    • 71749105108 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-analysis of randomised controlled trials
    • De Berardis G, Sacco M, Strippoli GF, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ. 2009; 339:b4531.
    • (2009) BMJ , vol.339 , pp. b4531
    • De Berardis, G.1    Sacco, M.2    Strippoli, G.F.3
  • 21
    • 79959345305 scopus 로고    scopus 로고
    • Effect of aspirin on mortality in the primary prevention of cardiovascular disease
    • Raju N, Sobieraj-Teague M, Hirsh J, O'Donnell M, Eikelboom J. Effect of aspirin on mortality in the primary prevention of cardiovascular disease. Am J Med. 2011; 124(7):621-629.
    • (2011) Am J Med. , vol.124 , Issue.7 , pp. 621-629
    • Raju, N.1    Sobieraj-Teague, M.2    Hirsh, J.3    O'Donnell, M.4    Eikelboom, J.5
  • 22
    • 84865457524 scopus 로고    scopus 로고
    • The aspirin controversy in primary prevention
    • Raju NC, Eikelboom JW. The aspirin controversy in primary prevention. Curr Opin Cardiol. 2012; 27(5):499-507.
    • (2012) Curr Opin Cardiol. , vol.27 , Issue.5 , pp. 499-507
    • Raju, N.C.1    Eikelboom, J.W.2
  • 23
    • 84857376799 scopus 로고    scopus 로고
    • Effect of aspirin on vascular and nonvascular outcomes: Meta-analysis of randomized controlled trials
    • Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med. 2012; 172(3):209-216.
    • (2012) Arch Intern Med. , vol.172 , Issue.3 , pp. 209-216
    • Seshasai, S.R.1    Wijesuriya, S.2    Sivakumaran, R.3
  • 24
    • 78651266855 scopus 로고    scopus 로고
    • Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
    • Stavrakis S, Stoner JA, Azar M, Wayangankar S, Thadani U. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Am J Med Sci. 2011; 341(1):1-9.
    • (2011) Am J Med Sci. , vol.341 , Issue.1 , pp. 1-9
    • Stavrakis, S.1    Stoner, J.A.2    Azar, M.3    Wayangankar, S.4    Thadani, U.5
  • 25
    • 84885136577 scopus 로고    scopus 로고
    • Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: A systematic review and overview of reviews
    • Sutcliffe P, Connock M, Gurung T, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess. 2013; 17(43):1-253.
    • (2013) Health Technol Assess , vol.17 , Issue.43 , pp. 1-253
    • Sutcliffe, P.1    Connock, M.2    Gurung, T.3
  • 26
    • 84891918487 scopus 로고    scopus 로고
    • Aspirin in primary prevention of cardiovascular disease and cancer: A systematic review of the balance of evidence from reviews of randomized trials
    • Sutcliffe P, Connock M, Gurung T, et al. Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One. 2013; 8(12):e81970.
    • (2013) PLoS One , vol.8 , Issue.12 , pp. e81970
    • Sutcliffe, P.1    Connock, M.2    Gurung, T.3
  • 27
    • 62549131608 scopus 로고    scopus 로고
    • Aspirin for the primary prevention of cardiovascular events: An update of the evidence for the US preventive services task force
    • Wolff T, Miller T, Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2009; 150(6):405-410.
    • (2009) Ann Intern Med. , vol.150 , Issue.6 , pp. 405-410
    • Wolff, T.1    Miller, T.2    Ko, S.3
  • 28
    • 77952685474 scopus 로고    scopus 로고
    • Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A meta-analysis
    • Younis N, Williams S, Ammori B, Soran H. Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother. 2010; 11(9):1459-1466.
    • (2010) Expert Opin Pharmacother. , vol.11 , Issue.9 , pp. 1459-1466
    • Younis, N.1    Williams, S.2    Ammori, B.3    Soran, H.4
  • 29
    • 74449086639 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
    • Zhang C, Sun A, Zhang P, et al. Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2010; 87(2):211-218.
    • (2010) Diabetes Res Clin Pract. , vol.87 , Issue.2 , pp. 211-218
    • Zhang, C.1    Sun, A.2    Zhang, P.3
  • 31
    • 84859327058 scopus 로고    scopus 로고
    • Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: Systematic review and multiple treatments meta-analysis
    • Fretheim A, Odgaard-Jensen J, Brørs O, et al. Comparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis. BMC Med. 2012; 10:33.
    • (2012) BMC Med. , vol.10 , pp. 33
    • Fretheim, A.1    Odgaard-Jensen, J.2    Brørs, O.3
  • 32
    • 67650082354 scopus 로고    scopus 로고
    • Use ofblood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
    • Law MR, Morris JK, Wald NJ. Use ofblood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338:b1665.
    • (2009) BMJ , vol.338 , pp. b1665
    • Law, M.R.1    Morris, J.K.2    Wald, N.J.3
  • 33
    • 84922753787 scopus 로고    scopus 로고
    • Effects of blood pressure reduction in mild hypertension: A systematic review and meta-analysis
    • Sundström J, Arima H, Jackson R, et al.; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of blood pressure reduction in mild hypertension: a systematic review and meta-analysis. Ann Intern Med. 2015; 162(3):184-191.
    • (2015) Ann Intern Med. , vol.162 , Issue.3 , pp. 184-191
    • Sundström, J.1    Arima, H.2    Jackson, R.3
  • 34
    • 85019356296 scopus 로고    scopus 로고
    • The benefits of statin therapy in patients without established cardiovascular disease but with cardiovascular risk factors: Meta-analysis of randomized controlled trials
    • Brugts JJ, Yetgin T, Hoeks SE, et al. The benefits of statin therapy in patients without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomized controlled trials. Eur Heart J. 2009; 30: 510-511.
    • (2009) Eur Heart J. , vol.30 , pp. 510-511
    • Brugts, J.J.1    Yetgin, T.2    Hoeks, S.E.3
  • 35
    • 77952061696 scopus 로고    scopus 로고
    • Statins for primary prevention of cardiovascular mortality in women: A systematic review and meta-analysis
    • Bukkapatnam RN, Gabler NB, Lewis WR. Statins for primary prevention of cardiovascular mortality in women: a systematic review and meta-analysis. Prev Cardiol. 2010; 13(2):84-90.
    • (2010) Prev Cardiol. , vol.13 , Issue.2 , pp. 84-90
    • Bukkapatnam, R.N.1    Gabler, N.B.2    Lewis, W.R.3
  • 36
    • 84857064061 scopus 로고    scopus 로고
    • Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: A meta-analysis
    • Chen YH, Feng B, Chen ZW. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis. Exp Clin Endocrinol Diabetes. 2012; 120(2):116-120.
    • (2012) Exp Clin Endocrinol Diabetes , vol.120 , Issue.2 , pp. 116-120
    • Chen, Y.H.1    Feng, B.2    Chen, Z.W.3
  • 37
    • 84933673677 scopus 로고    scopus 로고
    • Efficacy and safety of LDL-lowering therapy among men and women: Meta-analysis of individual data from 174,000 participants in 27 randomised trials
    • Fulcher J, O'Connell R, Voysey M, et al.; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials. Lancet. 2015; 385(9976):1397-1405.
    • (2015) Lancet. , vol.385 , Issue.9976 , pp. 1397-1405
    • Fulcher, J.1    O'Connell, R.2    Voysey, M.3
  • 38
    • 84864832599 scopus 로고    scopus 로고
    • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: Meta-analysis of individual data from 27 randomised trials
    • Mihaylova B, Emberson J, Blackwell L, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012; 380(9841):581-590.
    • (2012) Lancet. , vol.380 , Issue.9841 , pp. 581-590
    • Mihaylova, B.1    Emberson, J.2    Blackwell, L.3
  • 39
    • 33646829645 scopus 로고    scopus 로고
    • Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials
    • Costa J, Borges M, David C, Vaz Carneiro A. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ. 2006; 332 (7550):1115-1124.
    • (2006) BMJ , vol.332 , Issue.7550 , pp. 1115-1124
    • Costa, J.1    Borges, M.2    David, C.3    Vaz Carneiro, A.4
  • 40
    • 85058197556 scopus 로고    scopus 로고
    • Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis [abstract]
    • Costanzo P, Perrone-Filardi P, Petretta M, et al. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis [abstract]. J Am Coll Cardiol. 2009; 53(10):A210.
    • (2009) J Am Coll Cardiol. , vol.53 , Issue.10 , pp. A210
    • Costanzo, P.1    Perrone-Filardi, P.2    Petretta, M.3
  • 41
    • 84871202527 scopus 로고    scopus 로고
    • Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: A meta-analysis
    • de Vries FM, Denig P, Pouwels KB, Postma MJ, Hak E. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: a meta-analysis. Drugs. 2012; 72(18): 2365-2373.
    • (2012) Drugs , vol.72 , Issue.18 , pp. 2365-2373
    • De Vries, F.M.1    Denig, P.2    Pouwels, K.B.3    Postma, M.J.4    Hak, E.5
  • 42
    • 55949096863 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular mortality and events with statin treatments: A network meta-analysis involving more than 65,000 patients
    • Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008; 52(22): 1769-1781.
    • (2008) J Am Coll Cardiol. , vol.52 , Issue.22 , pp. 1769-1781
    • Mills, E.J.1    Rachlis, B.2    Wu, P.3    Devereaux, P.J.4    Arora, P.5    Perri, D.6
  • 43
    • 70749087459 scopus 로고    scopus 로고
    • Impact of gender in primary prevention of coronary heart disease with statin therapy: A meta-analysis
    • Petretta M, Costanzo P, Perrone-Filardi P, Chiariello M. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. 2010; 138(1): 25-31.
    • (2010) Int J Cardiol. , vol.138 , Issue.1 , pp. 25-31
    • Petretta, M.1    Costanzo, P.2    Perrone-Filardi, P.3    Chiariello, M.4
  • 44
    • 77954179995 scopus 로고    scopus 로고
    • Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65,229 participants
    • Ray KK, Seshasai SR, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med. 2010; 170(12):1024-1031.
    • (2010) Arch Intern Med. , vol.170 , Issue.12 , pp. 1024-1031
    • Ray, K.K.1    Seshasai, S.R.2    Erqou, S.3
  • 45
    • 70249094944 scopus 로고    scopus 로고
    • Statins for the primary prevention of cardiovascular disease
    • Taylor F, Huffman MD, Macedo AF, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013; 1: CD004816.
    • (2013) Cochrane Database Syst Rev. , vol.1 , pp. CD004816
    • Taylor, F.1    Huffman, M.D.2    Macedo, A.F.3
  • 46
    • 33751507008 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular diseases with statin therapy: A meta-analysis of randomized controlled trials
    • Thavendiranathan P, Bagai A, Brookhart MA, Choudhry NK. Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166(21):2307-2313.
    • (2006) Arch Intern Med. , vol.166 , Issue.21 , pp. 2307-2313
    • Thavendiranathan, P.1    Bagai, A.2    Brookhart, M.A.3    Choudhry, N.K.4
  • 47
    • 84965099454 scopus 로고    scopus 로고
    • Nicotine receptor partial agonists for smoking cessation
    • Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2012; 4(4):CD006103.
    • (2012) Cochrane Database Syst Rev. , vol.4 , Issue.4 , pp. CD006103
    • Cahill, K.1    Stead, L.F.2    Lancaster, T.3
  • 48
    • 84891791619 scopus 로고    scopus 로고
    • Pharmacological interventions for smoking cessation: An overview and network meta-analysis
    • Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013; 5:CD009329.
    • (2013) Cochrane Database Syst Rev. , vol.5 , pp. CD009329
    • Cahill, K.1    Stevens, S.2    Perera, R.3    Lancaster, T.4
  • 50
    • 85042045862 scopus 로고    scopus 로고
    • Population-based smoking cessation strategies: A summary of a select group of evidence-based reviews
    • Health Quality Ontario. Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews. Ont Health Technol Assess Ser. 2010; 10(1):1-44.
    • (2010) Ont Health Technol Assess Ser. , vol.10 , Issue.1 , pp. 1-44
  • 51
    • 0029914622 scopus 로고    scopus 로고
    • Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
    • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17(1):1-12.
    • (1996) Control Clin Trials , vol.17 , Issue.1 , pp. 1-12
    • Jadad, A.R.1    Moore, R.A.2    Carroll, D.3
  • 52
    • 0032417075 scopus 로고    scopus 로고
    • The delphi list: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by delphi consensus
    • Verhagen AP, de Vet HC, de Bie RA, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998; 51(12):1235-1241.
    • (1998) J Clin Epidemiol. , vol.51 , Issue.12 , pp. 1235-1241
    • Verhagen, A.P.1    De Vet, H.C.2    De Bie, R.A.3
  • 53
    • 84919346036 scopus 로고    scopus 로고
    • Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: A randomized clinical trial
    • Ikeda Y, Shimada K, Teramoto T, et al. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial. JAMA. 2014; 312(23):2510-2520.
    • (2014) JAMA , vol.312 , Issue.23 , pp. 2510-2520
    • Ikeda, Y.1    Shimada, K.2    Teramoto, T.3
  • 54
    • 84893863909 scopus 로고    scopus 로고
    • Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: A record linkage study
    • McConnachie A, Walker A, Robertson M, et al. Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study. Eur Heart J. 2014; 35(5):290-298.
    • (2014) Eur Heart J. , vol.35 , Issue.5 , pp. 290-298
    • McConnachie, A.1    Walker, A.2    Robertson, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.